SCHEMBL4433912

SCHEMBL4433912

CC(=O)c1ccc(N(C(=O)OC(C)(C)C)C2CCCNC2)c(N)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.35
CREBBP Q92793 1/20 0.34
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34
CHRND Q07001 1/20 0.34
KCNH2 Q12809 3/20 0.34
SLC6A2 P23975 3/20 0.33
SLC6A4 P31645 3/20 0.33
SLC6A3 Q01959 2/20 0.33
CHEK1 O14757 1/20 0.33
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
CCNT1 O60563 1/20 0.32
CCNK O75909 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4431999 0.90 MEN1 (0.34) FLT3KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL4438021 0.88 KCNH2 (0.37) KCNH2SLC6A2SLC6A4SLC6A3CHEK1
SCHEMBL4443673 0.88 RPLP1 (0.34) KCNH2SLC6A2SLC6A4SLC6A3PCSK9
SCHEMBL4437622 0.87 GAA (0.35) CREBBPCHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL4437552 0.87 SLC6A2 (0.39) KCNH2SLC6A2SLC6A4SLC6A3GAA
SCHEMBL4445222 0.86 RPLP1 (0.40) KCNH2CHEK1MAPTPCSK9RPLP1
SCHEMBL4444773 0.84 HTT (0.38) GAAMAPTNPC1GPR119
SCHEMBL4434418 0.81 RPLP1 (0.34) KCNH2SLC6A2SLC6A4SLC6A3PCSK9
SCHEMBL4436048 0.80 RPLP1 (0.36) KCNH2PCSK9RPLP1RPLP0RPS17
SCHEMBL3410670 0.80 RPLP1 (0.36) KCNH2PCSK9RPLP1RPLP0RPS17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed